{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:05Z","timestamp":1792511285686,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T00:00:00Z","timestamp":1391644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-65","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T18:01:55Z","timestamp":1391709715000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antimicrobial susceptibility\/resistance and genetic characteristics of Neisseria gonorrhoeaeisolates from Poland, 2010-2012"],"prefix":"10.1186","volume":"14","author":[{"given":"Beata","family":"Mlynarczyk-Bonikowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka Beata","family":"Serwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Golparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Walter de Walthoffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Koper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Malejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Domeika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"key":"3013_CR1","volume-title":"Global incidence and prevalence of selected curable sexually transmitted infections - 2008","author":"World Health Organization","year":"2012","unstructured":"World Health Organization: Global incidence and prevalence of selected curable sexually transmitted infections - 2008. 2012, Geneva: World Health Organization, Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/2008_STI_estimates.pdf (Accessed: January 19, 2014)"},{"key":"3013_CR2","volume-title":"Sexually Transmitted Infections in Europe 2011","author":"European Centre for Disease Prevention and Control","year":"2013","unstructured":"European Centre for Disease Prevention and Control: Sexually Transmitted Infections in Europe 2011. 2013, ECDC, Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/publications\/sexually-transmitted-infections-europe-2011.pdf (Accessed: January 19, 2014)"},{"key":"3013_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","volume":"7","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW, Ndowa F, Lewis DA, et al: Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009, 7: 821-834. 10.1586\/eri.09.63.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3013_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/sti.2010.042648","volume":"86","author":"DA Lewis","year":"2010","unstructured":"Lewis DA: The gonococcus fights back: is this time a knock out?. Sex Transm Infect. 2010, 86: 415-421. 10.1136\/sti.2010.042648.","journal-title":"Sex Transm Infect"},{"key":"3013_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo M, Nicholas RA: Emergence of multi-drug resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012, 7: 1401-1422. 10.2217\/fmb.12.117.","journal-title":"Future Microbiol"},{"key":"3013_CR6","volume-title":"Antimicrobial resistance in Neisseria gonorrhoeae. WHO\/CDS\/DRS\/2001.3:16","author":"J Tapsall","year":"2001","unstructured":"Tapsall J: Antimicrobial resistance in Neisseria gonorrhoeae. WHO\/CDS\/DRS\/2001.3:16. 2001, Geneva: World Health Organisation (WHO)"},{"key":"3013_CR7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","volume":"13","author":"S Yokoi","year":"2007","unstructured":"Yokoi S, Deguchi T, Ozawa T, et al: Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007, 13: 1275-1277.","journal-title":"Emerg Infect Dis"},{"key":"3013_CR8","volume-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England","author":"CA Ison","year":"2011","unstructured":"Ison CA, Hussey J, Sankar KN, et al: Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2011, 16 (14): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19833"},{"key":"3013_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, et al: High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012, 56: 1273-1280. 10.1128\/AAC.05760-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR10","volume-title":"First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011","author":"M Unemo","year":"2011","unstructured":"Unemo M, Golparian D, Stary A, et al: First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 2011, 16 (43): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19998"},{"key":"3013_CR11","volume-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","author":"M Unemo","year":"2010","unstructured":"Unemo M, Golparian D, Syversen G, et al: Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010, 15 (47): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19721"},{"key":"3013_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, M\u00fcller EE, et al: Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013, 68: 1267-1270. 10.1093\/jac\/dkt034.","journal-title":"J Antimicrob Chemother"},{"key":"3013_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","volume":"309","author":"VG Allen","year":"2013","unstructured":"Allen VG, Mitterni L, Seah C, et al: Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA. 2013, 309: 163-170. 10.1001\/jama.2012.176575.","journal-title":"JAMA"},{"key":"3013_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","volume":"58","author":"J Tapsall","year":"2009","unstructured":"Tapsall J, Read P, Carmody C, et al: Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009, 58: 683-687. 10.1099\/jmm.0.007641-0.","journal-title":"J Med Microbiol"},{"key":"3013_CR15","volume-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","author":"M Unemo","year":"2011","unstructured":"Unemo M, Golparian D, Hestner A: Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011, 16 (6): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19792"},{"key":"3013_CR16","volume-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Potocnik M, et al: Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012, 17 (25): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=20200"},{"key":"3013_CR17","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, et al: Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011, 55: 3538-3545. 10.1128\/AAC.00325-11.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/jac\/dkt017","volume":"68","author":"YM Chen","year":"2013","unstructured":"Chen YM, Stevens K, Tideman R, et al: Failure of ceftriaxone 500\u00a0mg to eradicate pharyngeal gonorrhoea, Australia. J Antimicrob Chemother. 2013, 68: 1445-1447. 10.1093\/jac\/dkt017.","journal-title":"J Antimicrob Chemother"},{"key":"3013_CR19","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J C\u00e1mara","year":"2012","unstructured":"C\u00e1mara J, Serra J, Ayats J, et al: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012, 67: 1858-1860. 10.1093\/jac\/dks162.","journal-title":"J Antimicrob Chemother"},{"key":"3013_CR20","first-page":"1","volume-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"World Health Organization (WHO), Department of Reproductive Health and Research","year":"2012","unstructured":"World Health Organization (WHO), Department of Reproductive Health and Research: Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. 2012, Geneva: WHO, 1-36. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501 (Accessed: January 19, 2014)"},{"key":"3013_CR21","first-page":"1","volume-title":"Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2012","unstructured":"European Centre for Disease Prevention and Control (ECDC): Response plan to control and manage the threat of multidrug-resistant gonorrhoea in Europe. 2012, Stockholm: ECDC, 1-23. Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1206-ECDC-MDR-gonorrhoea-response-plan.pdf (Accessed: January 19, 2014)"},{"key":"3013_CR22","first-page":"1","volume-title":"Cephalosporin-resistant Neisseria gonorrhoeae public health response plan","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC): Cephalosporin-resistant Neisseria gonorrhoeae public health response plan. 2012, CDC, 1-43. Available at: http:\/\/www.cdc.gov\/std\/treatment\/ceph-r-responseplanjuly30-2012.pdf (Accessed: January 19, 2014)"},{"key":"3013_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M, on behalf of the European STI Guidelines Editorial Board: European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013, 24: 85-92. 10.1177\/0956462412472837.","journal-title":"Int J STD AIDS"},{"key":"3013_CR24","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","volume":"46","author":"S Ameyama","year":"2002","unstructured":"Ameyama S, Onodera S, Takahata M, et al: Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother. 2002, 46: 3744-3749. 10.1128\/AAC.46.12.3744-3749.2002.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","volume":"49","author":"M Ito","year":"2005","unstructured":"Ito M, Deguchi T, Mizutani KS, et al: Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in central Japan. Antimicrob Agents Chemother. 2005, 49: 137-143. 10.1128\/AAC.49.1.137-143.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/jac\/dkp505","volume":"65","author":"SG Lee","year":"2010","unstructured":"Lee SG, Lee H, Jeong SH, et al: Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother. 2010, 65: 669-675. 10.1093\/jac\/dkp505.","journal-title":"J Antimicrob Chemother"},{"key":"3013_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","volume":"14","author":"K Osaka","year":"2008","unstructured":"Osaka K, Takakura T, Narukawa K, et al: Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother. 2008, 14: 195-203. 10.1007\/s10156-008-0610-7.","journal-title":"J Infect Chemother"},{"key":"3013_CR28","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1128\/AAC.00626-06","volume":"50","author":"S Takahata","year":"2006","unstructured":"Takahata S, Senju N, Osaki Y, et al: Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2006, 50: 3638-3645. 10.1128\/AAC.00626-06.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR29","doi-asserted-by":"publisher","first-page":"8062","DOI":"10.1021\/bi101167x","volume":"49","author":"J Tomberg","year":"2010","unstructured":"Tomberg J, Unemo M, Davies C, et al: Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry. 2010, 49: 8062-8070. 10.1021\/bi101167x.","journal-title":"Biochemistry"},{"key":"3013_CR30","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.00304-09","volume":"53","author":"S Zhao","year":"2009","unstructured":"Zhao S, Duncan M, Tomberg J, et al: Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother. 2009, 53: 3744-3751. 10.1128\/AAC.00304-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3013_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1128\/CMR.00040-10","volume":"24","author":"M Unemo","year":"2011","unstructured":"Unemo M, Dillon JA: Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev. 2011, 24: 447-458. 10.1128\/CMR.00040-10.","journal-title":"Clin Microbiol Rev"},{"key":"3013_CR32","first-page":"5","volume-title":"Zapalenia cewki moczowej i narz\u0105du rodnego in: Post\u0119powanie w przypadku rozpoznania chor\u00f3b przenoszonych drog\u0105 p\u0142ciow\u0105: Czelej","author":"S Majewski","year":"2000","unstructured":"Majewski S, Rudnicka I, Dajek Z: Zapalenia cewki moczowej i narz\u0105du rodnego in: Post\u0119powanie w przypadku rozpoznania chor\u00f3b przenoszonych drog\u0105 p\u0142ciow\u0105: Czelej. 2000, Lublin, 5-8. In Polish, 1, In Polish","edition":"1"},{"key":"3013_CR33","first-page":"457","volume-title":"Choroby sk\u00f3ry i choroby przenoszone drog\u0105 plciowa","author":"S Jablonska","year":"2010","unstructured":"Jablonska S, Majewski S: Choroby przenoszone droga p\u0142ciowa. Choroby sk\u00f3ry i choroby przenoszone drog\u0105 plciowa. 2010, Polish: PZWL Warsaw, 457-507."},{"key":"3013_CR34","first-page":"1151","volume":"29","author":"B Hoffmann","year":"1974","unstructured":"Hoffmann B, Monsiorska-Borowska Z, Araszkiewicz M, et al: Assessment of sensitivity to penicillin and other antibiotics in Neisseria gonorrhoeae in Poland in 1973. Pol Tyg Lek. 1974, 29: 1151-1154. In Polish","journal-title":"Pol Tyg Lek"},{"key":"3013_CR35","first-page":"377","volume":"62","author":"E Michalska-Trenkner","year":"1975","unstructured":"Michalska-Trenkner E, Dratwi\u0144ski Z, Wiewi\u00f3rkowska L: Drug resistance of Neisseria gonorrhoeae in the Gdansk Province. Przegl Dermatol. 1975, 62: 377-382. In Polish","journal-title":"Przegl Dermatol"},{"key":"3013_CR36","first-page":"487","volume":"66","author":"A Stapinski","year":"1979","unstructured":"Stapinski A, Mroczkowski TF, Dajek Z, et al: 1st cases of gonorrhea caused by penicillinase-producing Neisseria gonorrhoeae in Poland. Przegl Dermatol. 1979, 66: 487-494. In Polish","journal-title":"Przegl Dermatol"},{"key":"3013_CR37","first-page":"115","volume":"63","author":"B Mlynarczyk-Bonikowska","year":"2011","unstructured":"Mlynarczyk-Bonikowska B, Przedpelska G, Malejczyk M, et al: Penicillinase production by Neisseria gonorrhoeae strains isolated from the patients of Dermatology and Wenerology Clinic, Warsaw Medical University in 2006\u20132009. Med Dosw Mikrobiol. 2011, 63: 115-120. In Polish","journal-title":"Med Dosw Mikrobiol"},{"key":"3013_CR38","first-page":"685","volume":"66","author":"H Linda","year":"1979","unstructured":"Linda H, Dzierzanowska D, Bramska S: Studies on the effectiveness of cephalosporins against Neisseria gonorrhoeae. Przegl Dermatol. 1979, 66: 685-688. In Polish","journal-title":"Przegl Dermatol"},{"key":"3013_CR39","first-page":"249","volume":"57","author":"JW Tapsall","year":"1981","unstructured":"Tapsall JW, Cheng JK: Rapid identification of pathogenic species of Neisseria by carbohydrate degradation tests: importance of glucose in media used for preparation of inocula. Br J Ven Dis. 1981, 57: 249-252.","journal-title":"Br J Ven Dis"},{"key":"3013_CR40","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JCM.40.10.3741-3749.2002","volume":"40","author":"M Unemo","year":"2002","unstructured":"Unemo M, Olcen P, Berglund T, et al: Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol. 2002, 40: 3741-3749. 10.1128\/JCM.40.10.3741-3749.2002.","journal-title":"J Clin Microbiol"},{"key":"3013_CR41","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/jac\/dkp098","volume":"63","author":"M Unemo","year":"2009","unstructured":"Unemo M, Fasth O, Fredlund H, et al: Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother. 2009, 63: 1142-1151. 10.1093\/jac\/dkp098.","journal-title":"J Antimicrob Chemother"},{"key":"3013_CR42","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1086\/383047","volume":"189","author":"IM Martin","year":"2004","unstructured":"Martin IM, Ison CA, Aanensen DM, et al: Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis. 2004, 189: 1497-1505. 10.1086\/383047.","journal-title":"J Infect Dis"},{"key":"3013_CR43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/j.1600-0463.2008.01062.x","volume":"116","author":"M Unemo","year":"2008","unstructured":"Unemo M, Olc\u00e9n P, Fredlund H, et al: Real-time PCR and subsequent pyrosequencing for screening of penA mosaic alleles and prediction of reduced susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae. APMIS. 2008, 116: 1004-1008. 10.1111\/j.1600-0463.2008.01062.x.","journal-title":"APMIS"},{"key":"3013_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","volume":"9","author":"T Deguchi","year":"2003","unstructured":"Deguchi T, Yasuda M, Yokoi S, et al: Treatment of uncomplicated gonococcal urethritis by double-dosing of 200\u00a0mg cefixime at a 6-h interval. J Infect Chemother. 2003, 9: 35-39. 10.1007\/s10156-002-0204-8.","journal-title":"J Infect Chemother"},{"key":"3013_CR45","volume-title":"Gonococcal antimicrobial susceptibility surveillance in Europe\u20132010","author":"European Centre for Disease Prevention and Control","year":"2012","unstructured":"European Centre for Disease Prevention and Control: Gonococcal antimicrobial susceptibility surveillance in Europe\u20132010. 2012, Stockholm: ECDC, Available at: http:\/\/www.ecdc.europa.eu\/en\/publications\/publications\/1206-gonococcal-amr.pdf (Accessed: January 19, 2014)"},{"key":"3013_CR46","volume-title":"The European gonococcal antimicrobial surveillance programme, 2009","author":"MJ Cole","year":"2011","unstructured":"Cole MJ, Unemo M, Hoffmann S, et al: The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. 2011, 16 (42): Available online: http:\/\/www.eurosurveillance.org\/ViewArticle.aspx?ArticleId=19995"},{"key":"3013_CR47","unstructured":"EpiNorth Network: A Co-operation Project for Communicable Disease Control in Northern Europe. Available at: http:\/\/www.epinorth.org (Accessed: January 19, 2014)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-65\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-65","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-65.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:06:01Z","timestamp":1746129961000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-65"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3013"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-65","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]},"assertion":[{"value":"2 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"65"}}